• Product NameTeniposide
• Brief DescriptionInhibitors
• Purification99.45%
• Biological ActivityTeniposide(VM-26) is a semisynthetic derivative of podophyllotoxin and are increasingly used in Y medicine; causing breaks in DNA via an interaction with DNA topoisomerase II.
• Target NameTopoisomerase inhibitor
• CAS No. 29767-20-2
• Calculated MW 656.66
• Formulation C32H32O13S
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Cancer
  SMILES:COC1=CC(=CC(=C1O)OC)[C@H]2[C@@H]3[C@H](COC3=O)[C@@H](C4=CC5=C(C=C24)OCO5)O[C@H]6[C@@H]([C@H]([C@H]7[C@H](O6)CO[C@H](O7)C8=CC=CS8)O)O
  Pathways:DNA Damage/DNA Repair
  Receptor:Topo II
  Boling pt:75-77C
  Melting pt:244-247C
  Solubility:DMSO: 40 mg/mL (60.91 mM)
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. de Lucio B, et al. Y Sci. 2005 Nov;96(11):774-83.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting